Home > Insider Trading > Filing (0001140361-12-022662)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1221590	Jacques Jean Bienaime	C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-04-30	1,098	$19.35	113,191	No	5	A	Direct
Common Stock	Acquisiton	2012-05-01	20,000	$9.86	133,191	No	4	M	Direct
Common Stock	Disposition	2012-05-01	20,000	$35.00	113,191	No	4	S	Direct
Common Stock	Acquisiton	2012-05-02	10,000	$9.86	123,191	No	4	M	Direct
Common Stock	Disposition	2012-05-02	10,000	$35.72	113,191	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	5	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2012-05-01	20,000	$0.00	20,000	$9.86
Common Stock	Stock Option (right to buy)	Disposition	2012-05-02	10,000	$0.00	10,000	$9.86

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,253,764	2006-05-11	2015-11-10	No	4	M	Direct
2,243,764	2006-05-11	2015-11-10	No	4	M	Direct

Footnotes

The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2011 to April 30, 2012.
Transaction made pursuant to a Rule 10b5-1 Trading plan executed on April 27, 2012.
The price in Column 4 is a weighted average price. The prices actually received ranged from $34.465 to $35.31. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price in Column 4 is a weighted average price. The prices actually received ranged from $34.755 to $36.32. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Original option grant vested 1/3 each on May 11, 2006, May 11, 2007, and May 11, 2008.